These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9873370)

  • 1. 5-Alkyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series.
    Vig R; Mao C; Venkatachalam TK; Tuel-Ahlgren L; Sudbeck EA; Uckun FM
    Bioorg Med Chem Lett; 1998 Jun; 8(12):1461-6. PubMed ID: 9873370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel derivatives of phenethyl-5-bromopyridylthiourea and dihydroalkoxybenzyloxopyrimidine are dual-function spermicides with potent anti-human immunodeficiency virus activity.
    D'Cruz OJ; Uckun FM
    Biol Reprod; 1999 Jun; 60(6):1419-28. PubMed ID: 10330101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptase.
    Sudbeck EA; Mao C; Vig R; Venkatachalam TK; Tuel-Ahlgren L; Uckun FM
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3225-33. PubMed ID: 9835518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Alkyl-2-[(aryl and alkyloxylcarbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series.
    He Y; Chen F; Sun G; Wang Y; De Clercq E; Balzarini J; Pannecouque C
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3173-6. PubMed ID: 15149669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided design, synthesis, and anti-HIV-1 activity in vitro of 2-alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as novel potent non-nucleoside reverse transcriptase inhibitors, also active against the Y181C variant.
    Ragno R; Mai A; Sbardella G; Artico M; Massa S; Musiu C; Mura M; Marturana F; Cadeddu A; La Colla P
    J Med Chem; 2004 Feb; 47(4):928-34. PubMed ID: 14761194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Zhang J; Zhan P; Wu J; Li Z; Jiang Y; Ge W; Pannecouque C; De Clercq E; Liu X
    Bioorg Med Chem; 2011 Jul; 19(14):4366-76. PubMed ID: 21683601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-HIV activity of three 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4 (3H)-one derivatives acting as non-nucleoside reverse transcriptase inhibitor in vitro.
    Long J; Zhang DH; Zhang GH; Rao ZK; Wang YH; Tam SC; He YP; Zheng YT
    Yao Xue Xue Bao; 2010 Feb; 45(2):228-34. PubMed ID: 21348416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship studies on new DABOS: effect of substitutions at pyrimidine C-5 and C-6 positions on anti-HIV-1 activity.
    Sbardella G; Mai A; Artico M; Chimenti P; Massa S; Loddo R; Marongiu ME; La Collat P; Pani A
    Antivir Chem Chemother; 2001 Jan; 12(1):37-50. PubMed ID: 11437321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives.
    Mai A; Artico M; Sbardella G; Massa S; Novellino E; Greco G; Loi AG; Tramontano E; Marongiu ME; La Colla P
    J Med Chem; 1999 Feb; 42(4):619-27. PubMed ID: 10052969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones.
    He Y; Chen F; Yu X; Wang Y; De Clercq E; Balzarini J; Pannecouque C
    Bioorg Chem; 2004 Dec; 32(6):536-48. PubMed ID: 15530994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 2-thioxopyrimidin-4(1H)-one derivatives as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Khalifa NM; Al-Omar MA
    Int J Mol Sci; 2014 Nov; 15(11):20723-35. PubMed ID: 25397597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of 6-substituted 5-alkyl-2-(phenylaminocarbonylmethylthio)pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs.
    Yu M; Li Z; Liu S; Fan E; Pannecouque C; De Clercq E; Liu X
    ChemMedChem; 2011 May; 6(5):826-33. PubMed ID: 21322110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chiral resolution and molecular modeling investigation of rac-2-cyclopentylthio-6-[1-(2,6-difluorophenyl)ethyl]-3,4-dihydro-5-methylpyrimidin-4(3H)-one (MC-1047), a potent anti-HIV-1 reverse transcriptase agent of the DABO class.
    Quaglia M; Mai A; Sbardella G; Artico M; Ragno R; Massa S; del Piano D; Setzu G; Doratiotto S; Cotichini V
    Chirality; 2001 Feb; 13(2):75-80. PubMed ID: 11170249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-nucleoside HIV reverse transcriptase inhibitors, Part 6[1]: synthesis and anti-HIV activity of novel 2-[(arylcarbonylmethyl)thio]-6-arylthio DABO analogues.
    Sun GF; Kuang YY; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    Arch Pharm (Weinheim); 2005 Oct; 338(10):457-61. PubMed ID: 16211654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Mai A; Sbardella G; Artico M; Ragno R; Massa S; Novellino E; Greco G; Lavecchia A; Musiu C; La Colla M; Murgioni C; La Colla P; Loddo R
    J Med Chem; 2001 Aug; 44(16):2544-54. PubMed ID: 11472208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity.
    Manetti F; Esté JA; Clotet-Codina I; Armand-Ugón M; Maga G; Crespan E; Cancio R; Mugnaini C; Bernardini C; Togninelli A; Carmi C; Alongi M; Petricci E; Massa S; Corelli F; Botta M
    J Med Chem; 2005 Dec; 48(25):8000-8. PubMed ID: 16335924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Ji L; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    J Med Chem; 2007 Apr; 50(8):1778-86. PubMed ID: 17381078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel C5 halogen-functionalized S-DABO as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Qin H; Liu C; Guo Y; Wang R; Zhang J; Ma L; Zhang Z; Wang X; Cui Y; Liu J
    Bioorg Med Chem; 2010 May; 18(9):3231-7. PubMed ID: 20371182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of chiral cyclopropyl dihydro-alkylthio-benzyl-oxopyrimidine (S-DABO) derivatives as potent HIV-1 reverse transcriptase inhibitors with high activity against clinically relevant mutants.
    Radi M; Maga G; Alongi M; Angeli L; Samuele A; Zanoli S; Bellucci L; Tafi A; Casaluce G; Giorgi G; Armand-Ugon M; Gonzalez E; Esté JA; Baltzinger M; Bec G; Dumas P; Ennifar E; Botta M
    J Med Chem; 2009 Feb; 52(3):840-51. PubMed ID: 19140683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship studies on potential non-nucleoside DABO-like inhibitors of HIV-1 reverse transcriptase.
    Costi R; Di Santo R; Artico M; Massa S; Lavecchia A; Marceddu T; Sanna L; La Colla P; Marongiu ME
    Antivir Chem Chemother; 2000 Mar; 11(2):117-33. PubMed ID: 10819436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.